CLEC-2/podoplanin and Thromboinflammation
Overview
Authors
Affiliations
Inhibition of SARS-CoV-2-mediated thromboinflammation by CLEC2.Fc.
Sung P, Sun C, Tao M, Hsieh S EMBO Mol Med. 2023; 15(7):e16351.
PMID: 37211986 PMC: 10331576. DOI: 10.15252/emmm.202216351.
Podoplanin: Its roles and functions in neurological diseases and brain cancers.
Wang Y, Peng D, Huang Y, Cao Y, Li H, Zhang X Front Pharmacol. 2022; 13:964973.
PMID: 36176432 PMC: 9514838. DOI: 10.3389/fphar.2022.964973.
Elevated Soluble Podoplanin Associates with Hypercoagulability in Patients with Nephrotic Syndrome.
Ji Y, Wang Y, Xu F, Jia X, Mu S, Lyu H Clin Appl Thromb Hemost. 2022; 28:10760296221108967.
PMID: 35862263 PMC: 9310221. DOI: 10.1177/10760296221108967.
The Role of CLEC-2 and Its Ligands in Thromboinflammation.
Meng D, Luo M, Liu B Front Immunol. 2021; 12:688643.
PMID: 34177942 PMC: 8220156. DOI: 10.3389/fimmu.2021.688643.
Interplay between Podoplanin, CD44s and CD44v in Squamous Carcinoma Cells.
Montero-Montero L, Renart J, Ramirez A, Ramos C, Shamhood M, Jarcovsky R Cells. 2020; 9(10).
PMID: 33003440 PMC: 7601683. DOI: 10.3390/cells9102200.